---
authors:
- Woolfolk, Kelsea
- Hughes, Jonathan
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36126016/
file_path: 2022/09/ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c.md
issue: '3'
keywords:
- Humans
- Glycosides
- Candidiasis, Vulvovaginal
- Female
- Triterpenes
last_updated: '2025-07-30'
mesh_terms:
- Candidiasis, Vulvovaginal
- Female
- Glycosides
- Humans
- Triterpenes
original_format: PubMed
pages: 324-325
patient_population: Adults
peer_reviewed: true
pmid: '36126016'
processed_date: '2025-07-30'
publication_date: '2022-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis.
topics:
- Family Medicine
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36126016'
  title: Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis.
  authors:
  - last_name: Woolfolk
    fore_name: Kelsea
    initials: K
    affiliation: Department of Pharmacy Services, Ascension Medical Group, Murfreesboro,
      Tennessee.
  - last_name: Hughes
    fore_name: Jonathan
    initials: J
    affiliation: Department of Pharmacy Services, Ascension Medical Group, Murfreesboro,
      Tennessee.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '3'
  publication_info:
    year: '2022'
    month: 09
    full_date: '2022-09-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Candidiasis, Vulvovaginal
    major_topic: true
    qualifiers:
    - qualifier: diagnosis
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Female
    major_topic: false
  - descriptor: Glycosides
    major_topic: false
  - descriptor: Humans
    major_topic: false
  - descriptor: Triterpenes
    major_topic: true
  publication_types: *id001
related_articles:
- pmid: '36126016'
  title: Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis.
  authors:
  - name: Woolfolk K
    authtype: Author
    clusterid: ''
  - name: Hughes J
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2022 Sep
- pmid: '34550113'
  title: Ibrexafungerp (Brexafemme) for vulvovaginal candidiasis.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2021 Sep 6
- pmid: '34548655'
  title: Ibrexafungerp to treat acute vulvovaginal candidiasis.
  authors:
  - name: Masone MC
    authtype: Author
    clusterid: ''
  source: Nat Rev Urol
  pubdate: 2021 Nov
- pmid: '36059275'
  title: Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp.
  authors:
  - name: Grant LM
    authtype: Author
    clusterid: ''
  - name: Orenstein R
    authtype: Author
    clusterid: ''
  source: J Investig Med High Impact Case Rep
  pubdate: 2022 Jan-Dec
- pmid: '34313977'
  title: 'Ibrexafungerp: First Approval.'
  authors:
  - name: Lee A
    authtype: Author
    clusterid: ''
  source: Drugs
  pubdate: 2021 Aug
---

# Ibrexafungerp (Brexafemme) for the Treatment of Vulvovaginal Candidiasis.

**Authors:** Woolfolk, Kelsea, Hughes, Jonathan

**Published in:** American family physician | Vol. 106, No. 3 | 2022-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36126016/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Candidiasis, Vulvovaginal, Female, Glycosides, Humans, Triterpenes

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36126016/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
